MaxWell Biosystems

MaxWell Biosystems (MxW) will provide the technology, data analysis and expertise related to electrophysiological in vitro testing of acute retinal preparations and retinal organoids. MxW has strong expertise in HD-MEA technology and related applications. Especially the focus of HyVIS on the fovea of the retina makes high-resolution HD-MEA an ideal tool to identify and analyse responses of retinal ganglion cells


  • Urs Frey, PhD

HyVIS is a research project funded from the European Union’s Horizon 2020 research and innovation actions (RIA) scheme under grant agreement no. 964468.